These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1086450)

  • 1. Plasma alpha-1-antitrypsin levels in early and late carcinoma of the cervix.
    Latner AL; Turner GA; Lamin MM
    Oncology; 1976; 33(1):12-4. PubMed ID: 1086450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment serum levels of C-reactive protein, alpha 1-antitrypsin, haptoglobin, alpha 1-acid glycoprotein and tissue polypeptide antigen in cervical carcinoma.
    Avall Lundqvist E; Blad E; Xiao L; Sjövall K; Eneroth P
    Eur J Gynaecol Oncol; 1991; 12(5):375-83. PubMed ID: 1717278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinase-inhibitor activity in sera of patients with carcinoma of the cervix uteri.
    Benítez-Bribiesca L; Freyre-Horta R; Villalobos-Ramírez M; Pastrana L
    Arch Invest Med (Mex); 1987; 18(3):187-92. PubMed ID: 3501277
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on seromucoid of patients with carcinoma of the uterine cervix.
    Lai C; Fujwara A
    Hiroshima J Med Sci; 1977 Dec; 26(4):297-301. PubMed ID: 307545
    [No Abstract]   [Full Text] [Related]  

  • 5. Review of cervical smears from 76 women with invasive cervical cancer: cytological findings and medicolegal implications.
    Coleman DV; Poznansky JJ
    Cytopathology; 2006 Jun; 17(3):127-36. PubMed ID: 16719855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of combined therapy on activity of cathepsin D and alpha-1-antitrypsin in the blood serum of women with cervical cancer.
    Woźniak B; Mila-Kierzenkowska C; Woźniak A; Drewa G; Sopońska M; Drewa T; Krzyzyńska-Malinowska E; Makarewicz R; Kowalski T; Szmytkowska K
    Eur J Gynaecol Oncol; 2008; 29(6):617-9. PubMed ID: 19115690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease and antiprotease concentrations in serum and vaginal fluid of patients with carcinoma of the cervix.
    Benítez-Bribiesca L; Freyre-Horta R; Gallegos-Vargas G
    Arch Invest Med (Mex); 1980; 11(4):523-45. PubMed ID: 7011240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of serum ferritin and acute phase reactant proteins levels in patients with cervical cancer].
    Xie JF
    Zhonghua Fu Chan Ke Za Zhi; 1991 Mar; 26(2):92-4, 124. PubMed ID: 1713541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic and treatment problems and prospects in precancerous and early stages of cervical cancer].
    Karag'ozov A
    Akush Ginekol (Sofiia); 1981; 20(4):331-7. PubMed ID: 7030097
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cervical cancer in Mecklenburg-Western Pomerania. Tumor stage, histological tumor type, age and screening participation of 985 patients].
    Marquardt K; Stubbe M; Broschewitz U
    Pathologe; 2016 Feb; 37(1):78-83. PubMed ID: 26660458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Protease-antiprotease balance in patients with invasive carcinoma of the cervix and uterus before and after radiotherapy].
    Benítez-Bribiesca L; de la Huerta-Sánchez R; Villanueva C; Freyre Horta R; Pastrana L; Guevara R
    Arch Invest Med (Mex); 1989; 20(1):9-21. PubMed ID: 2788398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The frequency and importance of gynaecological screening in older women (author's transl)].
    Kubista E; Nezbeda J
    Wien Klin Wochenschr; 1980 Jul; 92(14):506-9. PubMed ID: 6933742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No increased risk for cervical cancer after a broader definition of a negative Pap smear.
    Rebolj M; van Ballegooijen M; van Kemenade F; Looman C; Boer R; Habbema JD
    Int J Cancer; 2008 Dec; 123(11):2632-5. PubMed ID: 18767046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of faecal alpha 1-antitrypsin: methodologies and clinical application.
    Choudhary S; Gibson PR; Deacon MC; Young GP
    J Gastroenterol Hepatol; 1996 Apr; 11(4):311-8. PubMed ID: 8713696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.
    Wallin KL; Wiklund F; Angström T; Bergman F; Stendahl U; Wadell G; Hallmans G; Dillner J
    N Engl J Med; 1999 Nov; 341(22):1633-8. PubMed ID: 10572150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan.
    Sung HY; Kearney KA; Miller M; Kinney W; Sawaya GF; Hiatt RA
    Cancer; 2000 May; 88(10):2283-9. PubMed ID: 10820350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytologic anamnesis of patients with invasive cervix cancer].
    Lasnik E; Breitenecker G
    Geburtshilfe Frauenheilkd; 1987 Aug; 47(8):555-7. PubMed ID: 3653669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cancer of the uterine cervix in 1990. Cervicovaginal smear is the only detection test].
    Bergeron C
    Presse Med; 1990 Jun; 19(22):1032-4. PubMed ID: 2141156
    [No Abstract]   [Full Text] [Related]  

  • 19. Early detection of precursors of cervical cancer with cervical cytology and visual inspection of cervix with acetic Acid.
    Dhaubhadel P; Vaidya A; Choudhary P
    JNMA J Nepal Med Assoc; 2008; 47(170):71-6. PubMed ID: 18709035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical diagnosis in microinvasive carcinoma of the uterine cervix.
    Liu WM; Chao KC; Kan YY; Yuan CC; Chen CJ; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Sep; 46(3):167-71. PubMed ID: 2178046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.